The future role of defibrillators in the management of atrial fibrillation

Current Opinion in Cardiology

Volumn 12, Issue 1, 1997, Pages 12-17

  Ayers, Gregory M ^a   Griffin, Jerry C ^a  

^a BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

CARDIOVERSION; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; ELECTRODE; ENERGY; HEART ATRIUM FIBRILLATION; HUMAN; PRIORITY JOURNAL; R WAVE; RECURRENT DISEASE; REVIEW;

EID: 0031049787     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199701000-00003     Document Type: Review

References (59)

1. Kannel W, Abbott RD, Savage DD, McNamara PM: Epidemiological features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982, 306:1018-1022.
2. Kannel W, Wolf PA: Epidemiology of atrial fibrillation. In Atrial Fibrillation: Mechanisms and Management. Edited by Falk RH, Podrid PJ. New York: Raven Press: 1992:81-92.
3. Coplen SE, Antman EM, Berlin JA, Hewitt P, Chalmers TC: Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials. Circulation 1990, 82:1106-1116.
4. Lau C, Leung W, Wong C: A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation. Am Heart J 1992, 124:645-650.
5. Anderson JL, Gilbert E, Alpert BL, et al.: Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. Circulation 1989, 80:1557-1570.
6. Antman EM, Beamer AD, Cantillon C, McNowan N, Friedman PL: Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new anti-arrhythmic drugs. J Am Coll Cardiol 1990, 15:698-707
7. Flaker GC, Blackshear JL, McBride R, Dronmal RA, Halperin JL, Chart RG: Antiarrythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992, 20:527-532.
8. Singh S, Saini RV, Di Marco J, Kluger J, Gold R, Chen YW: Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. Am J Cardiol 1991, 68:1227-1 230.
9. Juul-Moller S, Edvardsson N, Rehnquist-Ahlberg N: Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. Circulation 1990, 82:1932-1939.
10. Zehender M, Hohnloser S, Muller B, Meinertz T, Just H: Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up. J Am Coll Cardiol 1992, 19:1054-1059.
11. Petersen P, Boysen G, Gotfredsen J, Anderson ED, Anderson B: Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen study. Lancet 1989, 28:175-179.
12. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators: The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990, 323:1505-1511.
13. Stroke Prevention in Atrial Fibrillation Investigators: Stroke prevention atrial fibrillation study. Circulation 1991, 84:527-539.
14. Connolly S, Laupacis A, Gent M, et al.: Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol 1991, 18:349-355.
15. Ewy GA: Optimal technique for electrical cardioversion of atrial fibrillation. Circulation 1992, 86:1645-1647.
16. Lown B, Perlroth MG, Kaidbey S, Tadaki A, Harken DE: "Cardioversion" of atrial fibrillation. N Engl J Med 1963, 269:325-331.
17. Lundstrom T, Ryden L: Chronic atrial fibrillation: Long-term results of direct current conversion. Acta Med Scand 1988, 223:53-59
18. Dalzel GW, Anderson J, Adgey AA: Factors determining success and energy requirements for cardioversion of atrial fibrillation. Q J Med 1990, 76:903-913.
19. Morris JJ, Peter R, McIntosh H: Electrical conversion of atrial fibrillation: immediate and long-term results and selection of patients. Ann Intern Med 1966, 65:216-231
20. Levy S, Lauribe L, Dolla E, et al.: A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992, 86:1415-1420.
21. Mower M, Mirowski M, Denniston R: Intraventricular defibrillation in dogs with impaired coronary artery circulation [abstract]. Clin Res 1972, 20:288.
22. Mirowski M, Mower M, Staewen W, Denniston RH, Tabatznik B, Mendeloff AL: Ventricular defibrillation through a single intravascular catheter electrode system [abstract]. Clin Res 1971, 19:328.
23. Schuder JC, Steoeckle H, Gold JH, West JA, Keskar PY: Experimental ventricular defibrillation with an automatic and completely implanted system. Trans Am Soc Amil Int Organs 1970, 16:207-212.
24. Mirowski M, Mower M, Staewen W, Tabatznik B, Mendeloff AL: Standby automatic defibrillator: an approach to prevention of sudden cardiac death. Arch Intern Med 1970, 126:158-161.
25. Mirowsky M, Mower M, Staewen W, Denniston RH, Mendeloff AL: The development of the transvenous automatic defibrillator. Arch Intern Med 1972, 239:773-779.
26. Mirowsky M, Mower M, Gott VL, Grawley RK: Feasibility and effectiveness of low-energy catheter defibrillation in man. Circulation 1973, 47:79-85.
27. Winkle RA, Back SM Jr, Mead RH, et al.: Comparison of defibrillation efficacy in humans using a new catheter and superior vena cava spring left ventricular patch electrode. J Am Coll Cardiol 1988, 11:365-370.
28. Saksena S, Parsonnet V: Implantation of a cardioverter defibrillation without thoracotomy using a triple electrode system. JAMA 1988, 259:69-72.
29. Bardy GH, Allen MD, Mehra R, Johnson G: An effective and adaptable transvenous defibrillation system using the coronary sinus in humans. J Am Coll Cardiol 1990, 16:887-895.
30. Bardy GH, Allen MD, Mehra R, et al.: Transvenous defibrillation in humans via the coronary sinus. Circulation 1990, 81:1252-1259.
31. Bardy GH, Troutman C, Johnson G, et al.: Electrode system influence on biphasic waveform defibrillation efficacy in humans. Circulation 1991, 84:665-671.
32. Bardy GH, Hofer B, Johnson G, et al.: Implantable transvenous cardioverter-defibrillators. Circulation 1993, 87:1152-1168.
33. Kudenchuk PJ, Bardy GH, Dolack GL, et al: Efficacy of a single-lead unipolar transvenous defibrillator compared with a system employing an additional coronary sinus electrode: a prospective randomized study. Circulation 1994, 89:2641-2644.
34. Cooper RAS, Alferness CA, Smith WA, Ideker RE: Internal cardioversion of atrial fibrillation in sheep. Circulation 1993, 87:1673-1686.
35. Keane D, Sulke N, Cooke R, et al.: Endocardial conversion of atrial flutter and fibrillation [abstract]. PACE 1993, 16:928
36. Johnson E, Yarger M, Wharton J: Monophasic and biphasic waveforms for low energy cardioversion of atrial fibrillation in humans [abstract]. Circulation 1993, 88:3184.
37. Johnson E, Smith W, Yarger MD, et al.: Clinical predictors of low-energy defibrillation thresholds in patients undergoing internal cardioversion of atrial fibrillation [abstract]. PACE 1994, 17:742
38. Murgatroyd FD, Slade AKB, Slade SM, et al.: Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans [abstract]. J Am Coll Cardiol 1995, 25:1347-1353.
39. Alt E, Schmitt C, Ammer R, et al.: Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE 1994, 17:1067-1078.
40. Alt E, Ammer R, Plewan A, et al.: Energy requirements for intracardiac low-energy cardioversion of chronic atrial fibrillation: comparison of different lead positions [abstract]. Circulation 1994, 92:1-473.
41. Saksena S, Prakash A, Mongeon L, et al.: Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Am J Cardlo 1995, 76:913-921.
42. Desai PK, Mangeon L, Conlon S, et al.: Is energy for transvenous defibrillation of atrial fibrillation (AF) with active pectoral can feasible? [abstract] Circulation 1995, 90:1-376.
43. Cmolik BL, Ortiz J, Ayers GM, Lee JH, Geha AS, Waldo AL: Successful • atrial defibrillation with very-low-energy shocks by means of temporary epicardial wire electrodes. J Thorac Cardiovasc Surg 1996, 111:392-398. In a canine sterile pericarditis model, biphasic shocks were found to be effective in cardioverting induced atrial fibrillation when delivered using a pair of temporary stainless steel wire electrodes placed overlying the right and left atrium. Atrial fibrillation was terminated with low voltage and energy requirements, suggesting that this is a practical approach to the management of postsurgical atrial fibrillation.
44. Ortiz J, Sokoloski MC, Ayers GM, Cmolik BL, Niwano S, Geha AS, Waldo AL, et al.: Atrial defibrillation using temporary epicardial defibrillation stainless steel wire electrodes: studies in the canine sterile pericarditis model. JACC 1995, 26:1356-1364.
45. Mehmanesh H, Haisch G, Lange R, et al.: Temporary Atrial Patch Electrode (TAPE): first report of a new method to treat supraventricular tachycardias after heart surgery [abstract]. PACE 1995, 18:901.
46. Levy S, Camm J: An implantable atrial defibrillator: an impossible dream? Circulation 1993, 87:1769-1771.
47. Ayers GM, Alferness CA, Ilina M, et al.: Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation 1994, 89:413-422.
48. Murgatroyd FO, Johnson EE, Cooper RAS, et al.: Safety of low-energy transvenous atrial defibrillation: world experience. Circulation 1994, 90:1-14.
49. Alt E, Ammer R, Schmitt C, Pasquantonio J, Plewan A, Leibig M, Schomig A: Pain threshold for internal cardioversion with low or no sedation [abstract]. PACE 1996, 19:737.
50. Lok NS, Lau CP, Lee KLF, et al.: Effect of different right atrial lead locations on the efficacy and tolerability of low energy transvenous atrial defibrillation with an implantable lead system [abstract]. PACE 1996, 19:633
51. Ayers GM, Griffin JC, Ilina M, Wagner DO, Sirokman WA, Bocek JM, White HF, Alferness CA: An implantable atrial defibrillator: initial animal experience with a novel device [abstract]. PACE 1994, 17:69
52. Sra J, Wharton M, Biblo L, for the METRIX System External Defibrillation •• Study Investigators: Feasibility of METRIX™ atrial defibrillation system in humans with atrial fibrillation [abstract]. J Am Coll Cardiol 1996, 27:375. The METRIX™ (Incontrol Inc., Redmond, VA) system properly detected sinus rhythm or atrial fibrillation and effectively delivered shocks to terminate atrial fibrillation in 10 patients. Additionally, it was found that the risk of ventricular proarrhythmia was low, suggesting that this is a feasible and promising device for treating atrial fibrillation.
53. Lau CP, Tse HF, Lee K, Lok NS, Ho DSW, Soffer M, Camm AJ: Initial •• clinical experience of a human implantable atrial defibrillator [abstract]. PACE 1996, 19:625. This study tested an implantable atrial defibrillator in three patients with paroxysmal atrial fibrillation. This early report showed that this is a well-tolerated and effective device for treating atrial fibrillation.
54. Haffajee C, Stevens S, Mangeon L, et al.: High frequency atrial burst pacing for termination of atrial fibrillation [abstract], PACE 1995, 18:804.
55. Saksena S, Giorgberidze J, Krol RB, Mathew P, Prakash A, Munsif AN: Clinical efficacy and electrophysiologic effects of high frequency atrial pacing for type 2 atrial flutter and fibrillation [abstract]. PACE 1995, 18:1120.
56. Swartz JF, Pellersels G, Silvers J, Patten L, Cervantez D: A catheter-based curative approach to atrial fibrillation in humans. Circulation 1994, 90:1-334.
57. Haissaguerre M, Gencel L, Fischer GB, LeMetayer P, et al.: Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 1994, 5:1045-1052.
58. Prakash A, Saksena S, Hill M, et al.: Outcome of patients with drug refractory atrial fibrillation/flutter and bradyarrhythmias using long-term dual site atrial pacing [abstract]. PACE 1995, 18:809
59. Daubert C, Gras D, Laciercq C, Baisset JM, Victor F, Mabo P: Biatrial synchronous pacing: a new therapeutic approach to prevent refractory atrial tachyarrhythmias [abstract]. J Am Coll Cardiol 1995, 230.